Christopher L Penney

This inventor holds 21 USPTO granted patents and 1 published patent application, plus 11 CIPO patents and 13 EPO patents. Top assignees: Prometic Biosciences Inc., Prometic Pharma Smt Limited, Biochem Pharma Inc.. Active years: 1997-2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Christopher L Penney. Retrieved from https://idiyas.com/inventor/christopher-l-penney

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 21 (Patent Applications = 1)

% Patents Active = 47.6

CIPO Patents = 11

EPO Patents = 13 (Patent Applications = 7)

Average Co-Inventor Count = 3.8

ph-index = 4

Forward Citations = 111(Granted Patents)

Location History:

Dollard des Ormeaux, CA (1997 - 1999)
Québec, CA (2014 - 2015)
Quebec, CA (1998 - 2017)
Pierrefonds, CA (2010 - 2020)

Company Filing History:

13 out of 30

Prometic Biosciences Inc.

patents

4 out of 12

Prometic Pharma Smt Limited

National Research Council of Canada

patents

Years Active: 1997-2020

Loading Chart...

21 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10815183 - Substituted aromatic compounds and pharmaceutical uses thereof (2020-10-27),

2. 9938221 - Substituted aromatic compounds and pharmaceutical uses thereof (2018-04-10),

3. 9682054 - Medium-chain length fatty acids, glycerides and analogues as stimulators of erythropoiesis (2017-06-20),

4. 9475750 - Phenylketone carboxylate compounds and pharmaceutical uses thereof (2016-10-25),

5. 9447016 - Method for the preparation of triglycerides of medium-chain length fatty acids (2016-09-20),

6. 9439882 - Compounds and compositions for the treatment of cancer (2016-09-13),

7. 9114118 - Compounds and compositions for the treatment of cancer (2015-08-25),

8. 8946190 - Medium-chain length fatty acids, salts and triglycerides in combination with gemcitabine for treatment of pancreatic cancer (2015-02-03),

9. 8927765 - Substituted aromatic compounds and pharmaceutical uses thereof (2015-01-06),

10. 8637574 - Salts of 3-pentylphenylacetic acid and pharmaceutical uses thereof (2014-01-28),

11. 8487001 - Medium-chain length fatty acids, glycerides and analogues as neutrophil survival and activation factors (2013-07-16),

12. 8258295 - Triazine derivatives, compositions containing such derivatives, and methods of treatment of cancer and autoimmune diseases using such derivatives (2012-09-04),

13. 8080555 - Purine derivatives and their use for treatment of autoimmune diseases (2011-12-20),

14. 8071580 - Medium-chain length fatty alcohols as stimulators of hematopoiesis (2011-12-06),

15. 7745488 - Medium-chain length fatty acids, glycerides and analogues as neutrophil survival and activation factors (2010-06-29),

Title: Christopher L Penney - Inventor from Quebec, CA

Introduction: Christopher L Penney is a renowned inventor based in Quebec, CA, known for his innovative contributions to various industries.

Latest Patents: Christopher L Penney holds several patents in the fields of technology, healthcare, and consumer products, showcasing his diverse range of expertise.

Career Highlights: With a career spanning over two decades, Christopher L Penney has been instrumental in developing cutting-edge solutions that have significantly impacted the market.

Collaborations: Throughout his career, Christopher L Penney has collaborated with leading companies, research institutions, and universities to bring his inventions to life and make a lasting impact on society.

Conclusion: Christopher L Penney's passion for innovation and his dedication to pushing the boundaries of what is possible make him a standout figure in the world of inventors.

Profile summary based on public USPTO records.